These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16411875)

  • 1. Succimer therapy for congenital lead poisoning from maternal petrol sniffing.
    Powell ST; Bolisetty S; Wheaton GR
    Med J Aust; 2006 Jan; 184(2):84-5. PubMed ID: 16411875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC).
    McKay CA
    J Med Toxicol; 2013 Dec; 9(4):339-43. PubMed ID: 24178899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA)) treatment of Andean children with environmental lead exposure.
    Counter SA; Ortega F; Shannon MW; Buchanan LH
    Int J Occup Environ Health; 2003; 9(2):164-8. PubMed ID: 12848245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead poisoning and chelation in a mother-neonate pair.
    Horowitz BZ; Mirkin DB
    J Toxicol Clin Toxicol; 2001; 39(7):727-31. PubMed ID: 11778671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of succimer chelation therapy on postural balance and gait outcomes in children with early exposure to environmental lead.
    Bhattacharya A; Shukla R; Auyang ED; Dietrich KN; Bornschein R
    Neurotoxicology; 2007 May; 28(3):686-95. PubMed ID: 17499360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group.
    Pediatr Res; 2000 Nov; 48(5):593-9. PubMed ID: 11044477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers.
    Burns CB; Currie B
    Aust N Z J Med; 1995 Jun; 25(3):197-203. PubMed ID: 7487685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Petrol sniffing in a pregnant Aboriginal population: a review of maternal and neonatal outcomes.
    Dodd J
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):420-3. PubMed ID: 11787917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute lead poisoning during the perinatal period. A case of encephalopathy in a six week old child treated by peritoneal dialysis].
    Besson-Leaud M; Lavaud J; Buneaux F; Gendrel D; Frejaville JP; Nordmann Y
    Ann Pediatr (Paris); 1977 May; 24(5):373-82. PubMed ID: 16211980
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal anomalies resulting from maternal bullet-related plumbism.
    Porter S; Hanley E; Sing RF
    J Trauma; 2004 Jun; 56(6):1353-5. PubMed ID: 15211150
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
    Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
    J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Labor at Term for Severe Antenatal Lead Poisoning.
    Mohan S; Mahonski S; Koziatek C; Cohen ET; Smith S; Su MK
    J Med Toxicol; 2023 Oct; 19(4):401-404. PubMed ID: 37365427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two dosing regimens of succimer in children with chronic lead poisoning.
    Farrar HC; McLeane LR; Wallace M; White K; Watson J
    J Clin Pharmacol; 1999 Feb; 39(2):180-3. PubMed ID: 11563411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.